Tress Capital

Tress Capital, LLC is a private equity firm established in 2013, based in New York, specializing in the cannabis sector. The firm focuses on various aspects of the industry, including lab testing, biotechnology, media, manufacturing, processing, cultivation, and technology, which encompasses both software and hardware solutions. Tress Capital invests globally, with a particular emphasis on regions such as the United States, Africa, the Middle East, Asia Pacific, Europe, and Latin America. The firm utilizes a combination of debt and equity financing to support its investments.

Jonathan Eisenberg

Partner of Capital

David Hess

Co-Founder and President

Eric R. London

Partner of Capital

Asher Troppe

Co-Founder and CEO

3 past transactions

Tyson 2.0

Series A in 2022
Tyson 2.0 is a cannabis company producing cannabis products known for purity, precision, and wide accessibility. Providing consumers an outstanding selection of products, Tyson 2.0 is an extraordinary balance of premium and affordable, full-spectrum cannabis flower, concentrates, and consumables available at retailers nationwide. The company is formed by the legendary boxer, entrepreneur, and icon Mike Tyson.

iCAN: israel-cannabis.com

Venture Round in 2019
iCAN is building the global cannabis ecosystem iCAN wants every person in the world to have access to medical-grade cannabis. We are building a portfolio of innovative companies across the entire global cannabis ecosystem. We identify and accelerate these companies and create synergies and cooperation across the ecosystem. iCAN uses its global network and reach to position Israel as the leading medical cannabis tech hub.

Turning Points Global

Acquisition in 2018
Turning Points Global, a cannabis advisory firm.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.